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An affective disorder in zebraﬁsh with mutation of the
glucocorticoid receptor
L Ziv1,2, A Muto1,7, PJ Schoonheim1,3, SH Meijsing4,8, D Strasser5, HA Ingraham4, MJM Schaaf3, KR Yamamoto4 and H Baier1,6
Upon binding of cortisol, the glucocorticoid receptor (GR) regulates the transcription of speciﬁc target genes, including those
that encode the stress hormones corticotropin-releasing hormone (CRH) and adrenocorticotropic hormone. Dysregulation of the
stress axis is a hallmark of major depression in human patients. However, it is still unclear how glucocorticoid signaling is linked
to affective disorders. We identiﬁed an adult-viable zebraﬁsh mutant in which the negative feedback on the stress response is
disrupted, due to abolition of all transcriptional activity of GR. As a consequence, cortisol is elevated, but unable
to signal through GR. When placed into an unfamiliar aquarium (‘novel tank’), mutant ﬁsh become immobile (‘freeze’), show
reduced exploratory behavior and do not habituate to this stressor upon repeated exposure. Addition of the antidepressant
ﬂuoxetine to the holding water and social interactions restore normal behavior, followed by a delayed correction of cortisol
levels. Fluoxetine does not affect the overall transcription of CRH, the mineralocorticoid receptor (MR), the serotonin transporter
(Serta) or GR itself. Fluoxetine, however, suppresses the stress-induced upregulation of MR and Serta in both wild-type ﬁsh and
mutants. Our studies show a conserved, protective function of glucocorticoid signaling in the regulation of emotional behavior
and reveal novel molecular aspects of how chronic stress impacts vertebrate brain physiology and behavior. Importantly, the
zebraﬁsh model opens up the possibility of high-throughput drug screens in search of new classes of antidepressants.
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Perception of a threatening environmental stimulus elicits
endocrine changes that in turn trigger a cascade of physiological
and behavioral processes. This so-called ‘stress response’ is mediated
by the hypothalamus--pituitary--adrenal (HPA) axis. Increased
synthesis and release of corticotropin-releasing hormone (CRH) in
the hypothalamus promote the release of adrenocorticotropic
hormone (encoded by the pomc gene) from the pituitary gland
into the circulation. Adrenocorticotropic hormone stimulates the
production of glucocorticoids in the adrenal gland, whose ﬁsh
homolog is named interrenal organ. In teleost ﬁsh and humans,
the major glucocorticoid hormone is cortisol (corticosterone in
rodents). Cortisol levels not only increase in response to stress, but
also exhibit a circadian rhythm, peaking during daytime in both
zebraﬁsh and humans.1,2
In humans, hyperactivity of the HPA axis is the most consistent
endocrine parameter associated with major depression.3,4 More-
over, even in non-diseased individuals, a high cortisol level in the
circulation (hypercortisolemia) is considered a risk factor, predis-
posing to the development of the disease.5 Correction, that is,
lowering of cortisol is often used clinically to monitor the success
of therapeutic intervention.4--6 Both extreme short-term stress and
mild chronic stress can precipitate affective disorders, including
depression and pathological anxiety, demonstrating a causal
contribution of stress to long-term mood changes. However, it is
unclear which component(s) of the HPA axis is/are responsible for
the neural circuitry changes that result in depression. There is no
obvious link between HPA-related hormones and the pharmaco-
logical treatments that have proven to be effective in many forms
of depression, such as benzodiazepines (e.g., diazepam¼ Valium),
which modulate gamma-aminobutyric acid type A receptors, and
selective serotonin reuptake inhibitors (SSRIs, e.g., ﬂuoxetine¼
Prozac).
Understanding the molecular crosstalk between the HPA axis
and depression is important, as it will inform the search for better
therapies. In the brain, cortisol is known to signal through a
ligand-dependent transcription factor, the glucocorticoid receptor
(GR). Upon binding of cortisol, GR forms homodimers and trans-
locates from the cytoplasm to the nucleus, where it binds speciﬁc
DNA sequences called glucocorticoid response elements (GREs),7
to regulate the expression of target genes in a tissue-speciﬁc
manner.8,9 These GREs are often highly conserved and can serve
as enhancers or repressors of gene transcription.10 GR can also form
heterodimers with other transcription factors, largely to repress
transcription of target genes. GR is ubiquitously expressed and is
only occupied by cortisol during the diurnal peaks or under stress.
A related factor, the mineralocorticoid receptor (MR), is more
sparsely expressed in the brain and has a 10-fold higher ligand
afﬁnity than GR. Together, MR and GR act over a wide range of
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cortisol concentrations. Signaling through GR, within the physio-
logical range, is thought to terminate the stress reaction and
facilitate recovery and memory storage.11
Both excess and shortage of GR signaling might be detrimental
to brain function. Some evidence exists in rodents that gluco-
corticoids have negative effects on neurogenesis and synaptic
plasticity in the hippocampus, and that these effects are reversed
by the SSRI administration over several weeks.12 On the other
hand, GR activity appears to be protective of the brain by dialing
down the stress response. In the latter view, depression is char-
acterized by ‘glucocorticoid resistance’, and the disease-causing
culprit is excess of some other hormone, perhaps CRH.4,5,13
In humans with functioning HPA axis, administration of dexa-
methasone (Dex, a synthetic ligand of GR) suppresses cortisol. In
depressed patients with hyperactivated HPA axis, however, this
effect is blunted.11 This is evidence in favor of glucocorticoid
resistance in at least some forms of major depression.
We have identiﬁed an adult viable zebraﬁsh mutant, grs357, in
which a single basepair change completely disrupts the GR
transcriptional regulation of its target genes. We show that ﬁsh
homozygous for the grs357 mutation display a hyperactivated
HPA axis, blunted suppression of cortisol by Dex and increased
depression-like behavior in response to mild stress. Diazepam and
ﬂuoxetine treatments, as well as social interactions, reverse the
abnormal behavior. These results reveal a phylogenetically con-
served link between the HPA axis and affective disorders in
vertebrates, and strongly support the view that glucocorticoid
resistance, and not excessive GR signaling, contribute to the
development of depression.
MATERIALS AND METHODS
Positional cloning and genotyping of grs357
By linkage mapping using 1230 meioses, the s357 mutation was mapped
to chromosome 14, between microsatellite markers z9017 (0.08 cM) and
z22094 (0.16 cM). Four partly overlapping BAC clones, zK10H23, zC221F10,
zC143O2 and zC119P14 covered this region (Zebraﬁsh Genome Finger-
printing Project; http://www.sanger.ac.uk/). By blasting GenScan-predicted
peptide sequences in this region to the NCBI protein database (http://
www.ncbi.nlm.nih.gov/), nine genes were identiﬁed. The zebraﬁsh kohtalo/
TRAP230 mutant complemented grs357, excluding this gene as a candidate
locus. Coding regions from the other eight genes were reverse-tran-
scriptase (RT)-PCR-ampliﬁed and sequenced. One mutation was found in
the GR cDNA, which was also conﬁrmed in the genomic sequence. The
wild-type (WT) cDNA sequence of GR matched NCBI accession number
AB218424.
All animals used for behavioral analysis were genotyped by using the
markers z9017 and z22094, which ﬂank the gr locus, on genomic DNA
template extracted from ﬁn clips or by mismatch PCR restriction-fragment
length polymorphism strategy on cDNA template. PCR primers (forward 50-
GGAAGAACTGACCTGCCTGT-30 ; reverse 50-TATCCGGCATAGAGGGTGTC-30)
were designed to add a DrdI site to the WT allele adjacent to the mutation
site. PCR products were then digested with DrdI and separated by 2%
agarose gel electrophoresis to identify carriers.
Cell culture, transient transfection and luciferase assay
Transcriptional activity was measured in two cell lines, U2OS and COS-7. To
transfect cells, WT (pCDNA3-GRWT) and mutant (pCDNA3-GRR443C) forms
of Flag-tagged GR constructs were made. Anti-FLAG antibody (Sigma,
St Louis, MO, USA) was used to detect GR by ﬂuorescent immunocyto-
chemistry. GRE-luciferase reporter gene was co-transfected, and luciferase
activity was measured following standard procedures.
To transfect U2OS cells, the following reporter plasmids were used: AP1-
Luc containing a single consensus activator protein-1 (AP-1) site upstream
of the thymidine kinase (TK) promoter, pOS-344-Luc containing the
344/þ 33 fragment of the osteocalcin gene, and NFkB-Luc containing a
single nuclear factor (NF)-kB site. U2OS human osteosarcoma cells were
maintained in Dulbecco’s modiﬁed Eagle’s medium (DMEM; GIBCO, Paisley,
UK) supplemented with 5% fetal bovine serum (FBS). For reporter activity
assays, cells were seeded into 24-well plates in DMEM/5% FBS at
approximately 20 000 cells per well. The following day, the cells were
transfected in FBS-free DMEM using 0.8ml of Lipofectamine and 1.6 ml of
PLUS reagent (Invitrogen, Paisley, UK) per well, with 20 ng reporter, and
20 ng of lacZ plus 100 ng empty plasmid p6R. After transfection (3 h), cells
were re-fed with DMEM/5% FBS, allowed to recover for 3 h, and either
re-fed with DMEM/5% FBS containing 100 nM Dex or ethanol vehicle
(AP-1 and osteocalcin reporters) for 12 h, or treated the next day with
ethanol vehicle, tumor necrosis factor (TNFa) (5 ngml1), or TNFa
(5 ngml1)þ 100 nM Dex for 6 h (NF-kB reporter). After treatment, cells
were lysed in 100ml per well of 1 lysis buffer (PharMingen, San Jose, CA,
USA) and assayed for luciferase and b-galactosidase activity.
Behavioral testing and image analysis
Experimental ﬁsh were recorded in 4--7 day intervals, once or twice a week.
As the HPA axis is under circadian regulation, all behavioral testing were
restricted to the early afternoon (5--8 h after light onset; 1300--1600 h).
Movies were recorded with a digital camera (HandyCam, Sony Electronics,
San Diego, CA, USA), transferred by Firewire to a computer, and saved on
the hard disk. Ofﬂine analysis was carried with custom-written software
in LabVIEW 8 (National Instruments, Austin, TX, USA) and Matlab 6.5
(MathWorks, Natick, MA, USA).
Drug treatments
Long-term drug treatments with ﬂuoxetine hydrochloride (Sigma, 0.8mM),
bupropion hydrochloride (Sigma, 3mM) and RU-486 (mifepristone, Sigma,
2.5--10mM) were conducted on groups of ﬁsh (n¼ 4 to 5) housed in 2-l
tanks (1.5 l water volume) with solvent for the drug serving as the control.
Drug-treated ﬁsh were fed once a day with live Artemia salina, followed
by replacement of the water and drug 1 h later. Short-term treatment
with diazepam (Sigma, 5 mM) was carried out by adding the drug to the
ﬁsh tank 30min before the assay. All drugs were also added to the water
of the tank in which the behavioral test was carried out. Treatment with
Dex (Sigma, 25 mM) was carried out by adding the drug to the ﬁsh tank
at 1800 h the day before the cortisol extraction. The next morning
(0900 h), ﬁsh were fed and Dex-containing water was replaced with
system water.
cDNA isolation and quantitative RT-PCR
Adult ﬁsh were killed by immersion in Tricaine (Western Chemicals,
Ferndale, WA, USA). RNA, extracted from fresh brains, was dissolved
immediately in Trizole reagent (Invitrogen) and kept on ice until processed
(10--40min). If brains were taken immediately following behavioral testing,
heads were ﬁrst frozen on dry ice and stored in 80 1C before dissection
and RNA extraction. cDNAs (Invitrogen) were prepared, and quantitative
RT-PCR (Applied Biosystems, Foster City, CA, USA) was performed
according to the manufacturers’ instructions. All RT-PCR expression data
were normalized to zebraﬁsh ppia-1 (NM199957).
Whole-mount RNA in-situ hybridization and vibratome sections
Adult ﬁsh were killed by immersion in Tricaine and ﬁxed in 4% para-
formaldehyde (Ted Pella, Redding, CA, USA) in phosphate-buffered saline
overnight in 4 1C or for 4 h at room temperature. Whole brains were
removed under a dissecting scope and stored in 100% methanol at 20 1C.
SP6 and T7 clones with fragments from the coding sequence of pomca
(NM_181438), crh (NM_0001007379) and serotonin transporter (serta;
NM_001039972) were used as templates to prepare digoxigenin-labeled
antisense riboprobes (Roche, Mannheim, Germany). Large probes were
further digested to 200--300 bp fragments. Whole mount in-situ hybridiza-
tions were performed following a standard protocol. Following hybridiza-
tion, brains were washed and mounted in 4% agarose (low melting
temperature, Invitrogen) in phosphate-buffered saline and sectioned at
100mm, using a vibratome (Leica Microsystems, Wetzlar, Germany). BM
Depression in a zebraﬁsh mutant
L Ziv et al
682
Molecular Psychiatry (2013), 681 -- 691 & 2013 Macmillan Publishers Limited
purple (Roche) substrate was used for AP staining. Images were captured
with a CCD camera, mounted on Leica stereoscope.
Cortisol measurement
Fish were anesthetized on ice, superﬁcially dried with a paper towel, and
the tail was removed. Blood was collected from the caudal vein with a
heparinized capillary (Fisher Scientiﬁc, Pittsburgh, PA, USA), preﬁlled with
sample buffer (1% bovine serum albumin (Sigma), 2 TIU Aprotinin (Sigma)
in phosphate-buffered saline). Either blood was blown out into a tube with
sample buffer to a ﬁnal amount of 20ml, or capillaries were directly
centrifuged in a 1.5-ml tube, and plasma was taken out of the capillary
using a gel-loading tip. Plasma was isolated by centrifugation at 4 1C,
3000g for 10min and stored at 80 1C. Cortisol plasma concentrations
were determined using an enzyme immunoassay kit (Cayman Chemicals,
Ann Arbor, MI, USA or Demeditec Diagnostics GmbH, Kiel-Wellsee,
Germany) or a Cortisol radioimmunoassay kit (COAT-A-COUNT, Siemens
Healthcare Diagnostics, Frimley, Camberley, UK). To reach the sensitive
range of the standard curve, plasma was diluted 1:25--60 (grþ /þ and
grs357/þ ) or 1:500--1000 (grs357/s357) with enzyme immunoassay buffer or
zero calibrator.
Statistical analysis
Statistical analysis was carried out with JMP8 software (SAS Institute,
Cary, NC, USA). In all graphs, error bars represent s.e.m. For statistical
comparisons, one-way or two-way analysis of variance, followed by
paired Student’s t-tests, were used. The Shapiro--Wilk test was used to
determine normal distributions.
RESULTS
The grs357 mutation generates an arginine (R) to cysteine (C)
substitution in the DNA-binding domain of GR
The grs357 mutant (originally named utoutos357) was identiﬁed in a
large-scale forward genetic screen for chemically induced point
mutations that disrupt larval behavior.14 The mutant larvae move
less actively than WT larvae at 6 days after fertilization (6 dpf), but
are morphologically indistinguishable from WT at all stages into
adulthood. We employed standard genetic mapping techniques
to identify the mutation in the zebraﬁsh genome. Homozygous
grs357 mutant larvae are somewhat darker than their WT siblings,
owing to dispersed melanin pigment in their melanophores.
This phenotype, which may be related to misregulation of
a-melanocyte-stimulating hormone (a peptide hormone encoded
by the pomc gene) was used to sort mutants from WT. A panel of
polymorphic simple-sequence repeats was scanned to identify
those that co-segregated with the mutant phenotype. About 600
individual homozygous mutants from a WIK/TL hybrid cross
(see Materials and Methods) were then used to reﬁne the chro-
mosomal location.
Narrowing the locus to a small region on chromosome 14 and
sequencing of positional candidates identiﬁed gr, the gene
encoding GR, as the mutated locus (Figure 1a). The zebraﬁsh
genome contains one copy of GR with high protein identity (47%)
to the human GR protein, especially in the DNA-binding domain
(97%) and the ligand-binding domain (73%).15 Sequencing of the
mutant cDNA showed a missense mutation that replaces an
arginine (R) at position 443 with a cysteine (C) in the DNA-binding
domain. This domain is essential for transcriptional regulation by
GR16--20 (Figure 1b-d). The protein structure model of GR (http://
www.rcsb.org/pdb/) predicts that the positive charge of this
arginine, which corresponds to R496 in rat, R484 in mouse and
R477 in human GR, is critically important for binding of the second
zinc ﬁnger knuckle to the negatively charged phosphate groups of
the DNA backbone.21 (Figure 1d). This suggested (and was veriﬁed
below) that the grs357 mutation generated a strong hypomorph or
null allele of GR.
The mutation spares hormone binding and nuclear translocation,
but eliminates transcriptional activity of GR
To determine which protein functions were disrupted by the
R443C mutation, we expressed Flag-tagged GR, with and without
the amino acid substitution, in COS-7 cells. In the absence of
ligand, anti-Flag antibody detected GR protein in both nucleus
and cytoplasm. In the presence of the synthetic GR ligand Dex,
both WT and mutant GRs were now exclusively found in the
nucleus (Figure 1e), indicating that neither hormone binding nor
subsequent nuclear translocation was disrupted by the mutation.
This is consistent with previous structural and functional studies
showing that nuclear translocation does not depend on the
protein domain carrying the substitution.16--20
To assay the effect of the R443C mutation on transcriptional
regulation by GR, WT or mutant GR were co-transfected with
reporter plasmids that recapitulated GR-dependent transcriptional
activation (GRE and GRE-tk) or repression (osteocalcin, AP-1,
NF-kB) in cell lines not expressing GR. Transcriptional activation
through direct binding to a strong GRE was abrogated in two
different cell lines (COS7 and U2OS), even at a Dex concentration
that exceeded the maximal effect in WT 10-fold (Figure 1f;
Supplementary Figure S1). Similarly, transcriptional repression,
which can either be mediated by direct DNA binding (osteo-
calcin; negative GRE) or by interaction with other transcription
factors, which tether GR to DNA (AP-1 and NF-kB), was also
disrupted (Figure 1g-i). Together our ﬁndings indicate that
transcriptional activity of GR is largely eliminated by the s357
mutation.
The stress axis is chronically elevated and dysregulated in the
mutant
Disruption of GR is expected to abrogate cortisol-mediated
negative feedback of physiological stress signals. Indeed, we
found substantially elevated cortisol levels in homozygous grs357
mutants (Figure 2a). Cortisol varied by a factor of three, between
individual animals, but was always several fold higher in mutants
(1--3 mgml1) than in WT sibling ﬁsh from the same tank (0.02--
0.2 mgml1). In WT, cortisol was slightly increased in response to
acute conﬁnement stress (keeping an adult ﬁsh in a narrow glass
tube for 10min; Figure 2a). Homozygous mutants did not exhibit a
further increase in cortisol following stress treatment, suggesting a
ceiling effect. Heterozygous carriers had higher cortisol levels than
WT in the non-stressed condition and responded more strongly to
conﬁnement stress, but never reached the levels seen in
homozygous mutants (Figure 2a, insert).
To investigate if negative feedback by GR on the HPA axis is
blunted by the mutation, we carried out a ‘Dex suppression test’.
Blood cortisol levels were measured in the early afternoon
(1300--1600 h, matching the time of the day in which behavioral
measurements were made, see below), following administration
of Dex or vehicle in the evening (1800 h) of the previous
day (lights were on from 0700 to 2100 h). Although in WT
and heterozygous carriers Dex treatment abolished the diurnal
cortisol increase, cortisol levels remained high in mutants
(Figure 2b), indicating resistance to glucocorticoids.
Quantitative real-time PCR on total RNA taken from the front
part of the brain (including telencephalon and anterior hypotha-
lamus) demonstrated chronic, two-fold increases of crh transcript
levels in mutants compared with heterozygotes (Figure 2c).
Elevated levels of crh mRNA were seen in the preoptic area of
the hypothalamus (the homolog of the mammalian paraventri-
cular nucleus22; Figure 2d) and the lateral tuberal nucleus
(Supplementary Figure S2). pomca mRNA was likewise globally
increased in mutants (data not shown), particularly in the lateral
tuberal nucleus (Figure 2e). Conﬁnement stress resulted in an
increase of crh and pomca transcripts by RT-PCR and in-situ
hybridization in heterozygotes, but had little, if any, effect in
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mutants (Figure 2c-e). Together, these changes in peptide
hormone expression indicate a lack of negative feedback on
gene transcription in the HPA axis.
Mutants freeze when placed in a novel tank and fail to habituate
to repeated stress treatments
To test if grs357 mutants showed abnormal stress-related behavior,
we observed the responses of WT, heterozygotes and mutants to a
mildly anxiogenic environment.23,24 Single male ﬁsh were placed
into a novel tank, which was well lit and had opaque, dark, non-
reﬂective walls. The novel-tank test was repeated twice a week
over 3 weeks. For each test, the swimming trajectory of the ﬁsh
was recorded with an overhead video camera, graphed over time,
and evaluated with respect to the animal’s location and speed
(Figure 3a, b). After 10min, the ﬁshes were returned to their
familiar community tanks. After being transferred into the novel
tank, the ﬁsh often stopped swimming and sank to the bottom of
the tank for 10 to 60 s, before resuming normal swimming for the
remainder of the observation period (Figure 3c; top panel shows
the velocity proﬁle of a representative WT ﬁsh after ﬁve previous
tests, in the third week after initial exposure to the novel tank).
Most ﬁsh reacted most strongly in the ﬁrst 60 s and then
habituated. In some ﬁsh, however, ‘freezing’ bouts could occur
through the entire observation period. Then, ﬁsh could be
immobile for up to 6min out of the 10-min observation period,
and show only short swimming bouts across the tank (Figure 3c;
bottom panel shows velocity proﬁle of a homozygous mutant with
prior exposure identical to the WT ﬁsh above).
Although the behavior was variable between individuals, parti-
cularly the initial freezing response (minute 1 of the test), we
observed strong population differences between the behavioral
patterns of mutant and WT ﬁsh. After,43 tests, each separated by
4 to 7 days of recovery, mutants froze signiﬁcantly more than WT
and heterozygous carriers. They spent a greater percentage of
time in an immobile state during the entire 10min (see Figure 3c).
We calculated the freezing index as the time spent without
moving, divided by the total observation time. Plotting the
freezing index showed signiﬁcant difference between mutants
and WT (Figure 3d). Genotype differences were not detectable at
the very ﬁrst exposure to the novel tank, but gradually developed
as a result of experience. WT ﬁsh froze less with each exposure,
apparently habituating to repeated isolation (Figure 3e; Supple-
mentary Figure S3a). Heterozygotes followed the WT trend, although
their freezing index revealed a slower time course of habituation
than WT (Figure 3e). In contrast, experienced mutants showed the
opposite trend over the course of 3 weeks; they spent increasingly
longer time freezing with each exposure, suggesting that they
became sensitized to the novel tank (Figure 3e; Supplementary
Figure S3b). Thus, zebraﬁsh with one or two WT copies of GR appear
to exhibit long-term (inter-trial) habituation to a novel tank,
whereas homozygous mutants become sensitized to the aversive
effects of this stressor. The conditioning regime chosen here thus
ampliﬁed behavioral differences between the genotypes.
Figure 1. Forward genetic identification and biochemical characterization of a mutation that disrupts transcriptional activity of the zebrafish
glucocorticoid receptor (GR). (a) BAC contig, spanning the interval between two microsatellite markers, z9017 and z22094. The region contains
nine predicted genes. (b) Genomic sequence alteration identified in the gr gene. (c) Sequence comparison of the zinc finger motif near the
mutated amino acid residue (in red, marked with *). Four conserved cysteines in the zinc finger are in bold. Non-conserved amino acids are in
blue. (d) Schematic of the zinc finger and the location of the arginine (R) to cysteine (C) substitution. (e) Subcellular localization of Flag-tagged
wild-type (WT) and R443C GR protein expressed in COS-7 cells and detected with anti-Flag antibody. Both showed nuclear translocation in the
presence of 1 mM dexamethasone (Dex). Scale bar is 10 mm. (f--i) GR (R443C) is defective in transcriptional repression. U2OS cells lacking
endogenous GR were co-transfected with either empty vector (‘0’), or expression constructs for either WT GR (WT) or mutant GR (R443C), and
reporter constructs for PRE-tk glucocorticoid response element (GRE; n¼ 2, Po0.0001) (f ); osteocalcin (nGRE; n¼ 5, Po0.0001) (g); AP-1 (n¼ 3,
P¼ 0.018) (h) or nuclear factor (NF)-kB (n¼ 4, P¼ 0.0037) (i). Cells were treated overnight with 100 nM Dex (PRE-tk, AP-1 and osteocalcin) or for
6 h with either ethanol vehicle, tumor necrosis factor alpha (TNFa), or TNFa plus 100 nM Dex (NF-kB). Reporter activity was expressed as fold
repression of Dex treated/EtOH vehicle (g, h) or relative luciferase units (f, i).
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Mutants show reduced wall exploration in the novel tank
We evaluated the locations of ﬁsh in the novel tank over the 10-min
test period, as a function of genotype and prior experience. ‘Heat
maps’ were generated that allowed us to visualize the cumulative
positions of the ﬁsh, with warmer colors representing preferred
areas of the tank and cooler colors representing areas that the ﬁsh
only rarely visit (Figure 3f). Place preference was calculated by
dividing the time spent in the central 50% of the tank volume
(away from the walls; as indicated in Figure 3g) by the total
observation time. This metric was termed ‘wall avoidance index’.
WT and heterozygotes showed no preference for the walls during
the ﬁrst exposures (Supplementary Figure S3c). With repeated
exposures, WT ﬁsh became increasingly likely to swim near the
walls (index drops from 40.5 to around 0.2; Figure 3h;
Supplementary Figure S3c, data collected from two different
cohorts of ﬁsh). Mutants exhibited a greater degree of wall
avoidance and did not habituate to weekly exposures, being
equally likely to be found near the perimeter as in the inner area
of the tank (index 0.5; Figure 3h; Supplementary Figure S3d). Thus,
ﬁsh with presumably higher levels of anxiety tended to avoid the
walls of the novel tank.
The behavioral differences between the genotypes, both in their
freezing responses and in their location preferences, could not be attri-
buted to a locomotor defect, as mutant ﬁsh swam with peak velocities
Figure 2. Hyperactivity of the hypothalamus--pituitary--adrenal (HPA) axis in grs357 mutant zebrafish. (a) Plasma cortisol levels determined by
enzyme immunoassay (EIA) before (non-stressed) and after confinement stress (stressed) in mutants (grs357/s357) compared with heterozygotes
(grs357/þ ). Insert shows cortisol of heterozygous (grs357/þ ) and wild-type (WT) fish (grþ /þ ) at different scale (n¼ 4--10 each). Cortisol is highest
in mutants. Cortisol is higher in heterozygotes than in WT. Stress increases cortisol in heterozygotes and WT (difference between grs357/s357
and grs357/þ : Po104, analysis of variance (ANOVA) F ratio¼ 160.24; difference between grs357/þ and grþ /þ : *P¼ 0.05; difference between
non-stress and stress: **P¼ 0.0051, ANOVA F ratio¼ 8.81; combined effect genotype stress P¼ 0.002, ANOVA F ratio¼ 10.99; pooled data
ANOVA: degrees of freedom¼ 3, F ratio¼ 60.82, Po104). (b) Dexamethasone (Dex) suppression test. Dex was added at 1800 h the day before.
Cortisol was measured at 1300--1600 h. Light on was at 0700 h. In WT and heterozygotes, the diurnal cortisol spike is greatly suppressed
(**Po103). Mutants show no reduction (P40.05;). (c) Reverse transcriptase (RT)-PCR expression of crh. RNA was extracted from the front part
of the brain (including telencephalon and anterior hypothalamus) in non-stressed and stressed fish (n¼ 3--9). crh mRNA is increased in
mutants (*Po0.05) and following confinement stress (**Po103). (d) Sagital sections showing crh-expressing cells in hypothalamic preoptic
area. More signal is seen in mutants. Drawings on the right indicate position of section in a side view of the zebrafish brain (top) and
boundaries of brain nuclei and ventricle at the level of the stained section (bottom). (e) Sagital sections showing pomca-expressing cells in the
lateral tuberal nucleus (NLT) of the hypothalamus. Mutants and stressed fish show stronger signal (drawings on the right, as in d).
Abbreviations: PPa and PPp, parvocellular preoptic nucleus, anterior and posterior parts; PM, magnocellular preoptic nucleus; VM,
ventromedial thalamic nucleus; TelV, telencephalic ventricle; DiV, diencephalic ventricle; SC, suprachiasmatic nucleus; CO, optic chiasm;
LH, lateral hypothalamic nucleus; Hv, ventral zone of periventricular hypothalamus; pit, pituitary.
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Figure 3. Exaggerated freezing responses and altered location preference in zebrafish grs357 mutants after isolation in a novel tank. Naive fish
were tested in the novel tank on day 0 (week 1) and then tested again every 4--7 days during the next 2 weeks (n¼ 4--8). Movements were
recorded every 15 s over 10min. (a) Trajectory of a representative wild-type (WT) fish after five exposures to the novel tank. (b) Trajectory of a
representative mutant after five exposures. The mutant swims significantly less than WT. (c) Plot of velocities over 10-min observation time.
WT (top) shows short-term habituation within the first minute and then swims at an approximately constant speed for 9min. Mutant (bottom)
is immobile half of the time and swims in short spurts. Peak velocities are similar to WT. (d) Freezing index (time spent immobile/observation
time) of experienced fish in novel tank. Data were pooled and averaged (grþ /þ , n¼ 47; grs357/þ , n¼ 115; grs357/s357, n¼ 134). The index drops
in the first minute, but remains high in mutants. WT freeze slightly less than heterozygotes. Freezing threshold (dotted line) is 1.6 cm s1. (e)
Freezing index, averaged over 9min. The first minute of the observation period (short-term habituation) was not included. WT and het-
erozygotes show long-term habituation over 3 weeks; they freeze gradually less. Mutants become more sensitized or are unchanged
(*Po0.05; **Po103). (f ) Heat maps, showing the spatial preferences of animals in the novel tank after five exposures. The spatial bin size is
10 10 pixels. Warmer colors represent preferred locations (see scale on the right). Mutants (bottom) spend less time near the perimeter of
the tank than WT (top) or heterozygotes (middle) (note the yellow and cyan pixels near the walls in the WT and heterozygotes). Orange and
red pixels indicate places where the fish froze. A greater number of red pixels are seen in the mutants, and they tend to be at a distance from
the walls. (g) Quantification of place preference. Video images of the tank were divided into two equally large compartments, as indicated.
The wall-avoidance index was calculated as the time spent in the central compartment divided by total observation time. (h) Wall avoidance in
experienced fish. Mutants remain in the central compartment (index ca. 0.5). WT prefers the periphery, after short-term habituation index
drops from 0.5 to 0.3. Heterozygotes show intermediate preferences. Error bars±s.e.m.
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very similar to WT, although their average velocities and their total
distances traveled were suppressed (Supplementary Figure S4a, b).
Social interactions reduce freezing responses of the mutant
Zebraﬁsh are highly social animals.25 According to the social
buffering paradigm,26 human subjects are less prone to the
anxiogenic effects of stressful environments when allowed inter-
action with other non-stressed group members and, inversely,
show increased stress responses when isolated. We asked if
freezing and place preference in the novel tank could be modiﬁed
by exposure to a conspeciﬁc. For this experiment, we varied the
conﬁguration, leaving one wall of the tank unoccluded, enabling
visual interaction with a WT ﬁsh in an adjacent tank (Figure 4a).
An empty tank served as a control. Analysis of swimming
trajectories (Figure 4b), cumulative ‘heat maps’ (Figure 4c) and
measurement of average positions (Figure 4d), all revealed a clear
tendency of zebraﬁsh, regardless of genotype, to spend more time
near the transparent wall. This tendency was stronger when
the neighboring tank contained a conspeciﬁc. Intriguingly, when
allowed visual interaction with other ﬁsh, mutants spent less time
freezing, approaching the levels of the heterozygotes (Figure 4e).
Reduced freezing was not associated with measurably lower
cortisol levels (Figure 4f). We conclude that social interactions
reversed freezing behavior in the mutant and did do so without
correcting the HPA axis.
Figure 4. Social interactions reduce freezing and wall avoidance in zebrafish grs357 mutants. (a) Top view of the experimental setup. The tested
fish are depicted in the bottom row of tanks. (a) Behavior was tested in the tank with one transparent wall, allowing visual interaction with a
non-mutant conspecific in a neighboring tank (‘view of other fish’, right panel). A standard tank with four opaque walls (‘isolated’, left panel)
and a tank with one transparent wall with view of an empty tank (‘view of empty tank’, middle panel) were used as controls. (b) Representative
trajectory of a mutant fish with view of a conspecific. (c) Heat maps, showing place preferences as in a. Heterozygotes (top panels) prefer the
walls and corners of the tanks, and particularly the wall that apposes the empty tank or the tank that contains the other fish. Isolated mutants
show no preference for the walls. However, they prefer to swim close to the transparent wall, particularly when the neighboring tank contains
another fish. (d) Average fish distance from the opaque versus transparent wall. The s.e.m. are smaller than the size of the marker diamond. (e)
Freezing indices for two genotypes (n¼ 9--19) as a function of their visual environment. Experienced mutants freeze much less when able to
view a conspecific (**P¼ 0.0013, analysis of variance (ANOVA) F ratio¼ 11.26; pooled data ANOVA: degrees of freedom¼ 5, F ratio¼ 4.64,
P¼ 0.001). Other differences were not statistically significant. (f ) Plasma cortisol, determined by enzyme immunoassay (EIA). Hormone levels
do not change in the behaviorally rescued mutants (n¼ 2--4).
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Acute diazepam and long-term ﬂuoxetine treatments reverse
depression-like behavior
To further investigate if freezing and reduced wall exploration
behavior involves neural circuits associated with depression
and/or anxiety, we treated ﬁsh with drugs known to have
antidepressant or anxiolytic effects in mammals. Diazepam binds
to the benzodiazepine-binding site of the gamma-aminobutyric
acid type A receptor, where it acts as a positive allosteric
modulator. Addition of diazepam (5mM for 30min) to the tank
water lowered the freezing response of experienced mutants to
levels seen in untreated heterozygotes (Figure 5a; Supplementary
Figure S5a). Wall exploration was likewise increased to levels seen
in untreated heterozygotes (Figure 5c; Supplementary Figure S5b).
Heterozygotes treated with diazepam showed the lowest-possible
freezing index (0; Figure 5a) and the lowest-measured wall
avoidance index (ca. 0.1; see Figure 5c, top-right panel). Treatment
with the SSRI ﬂuoxetine (0.8mM) had a similar effect, when
administered over 4 days, but not after shorter treatments
(Figure 5b; Supplementary Figure S5c, d). Neither diazepam nor
ﬂuoxetine altered average swimming speeds in either mutants or
heterozygotes (Supplementary Figure S4c), indicating that these
drugs did not exert sedative or other undesirable effects at the
concentrations used. The selective norepinephrine and dopamine
reuptake inhibitor bupropion (3 mM) had no effect on freezing
behavior (Supplementary Figure S6a). As expected, the potent GR
antagonist RU486 (5mM) had no behavioral effects on the mutants
(Supplementary Figure S6b-d). However, RU486 increased freezing
responses in WT, without affecting swimming speed or place
preference (Supplementary Figure S6e-g), thus partially phenoco-
pying the mutation.
We next asked if ﬂuoxetine treatment lowered cortisol levels in
stressed ﬁsh and/or corrected cortisol in behaviorally rescued
mutants. After 4 days of treatment, that is, immediately after the
behavioral test, cortisol was unchanged (Figure 5d). However,
following 2 weeks of continuous ﬂuoxetine treatment, cortisol was
substantially reduced, albeit not to the comparatively low levels
seen in heterozygotes and WT (Figure 5e). Therefore, cortisol
correction follows on the heels of, but is apparently not necessary
for, behavioral improvement.
Fluoxetine and the grs357 mutation reveal crosstalk between
glucocorticoid signaling and the serotonergic system
To better understand how SSRIs impinge on the stress axis, we
measured the expression levels of GR and MR by qRT-PCR,
following chronic mild stress (CMS) treatment. CMS was produced
by isolating a ﬁsh for up to 2 weeks, with regular ad libitum
feeding and daily handling. We found that gr mRNA itself was
slightly but consistently increased (by ca. 25%) in the grs357 mutant
and was not detectably changed by CMS and the experimental
conditions used here. Fluoxetine had subtle, if any, effects on gr
expression (Figure 5f). Transcript levels of mr, the gene encoding
the MR, were similar for all genotypes, suggesting that MR is not
regulated by GR (Figure 5g). Following CMS, mr mRNA was
signiﬁcantly increased (by ca. 100%); ﬂuoxetine administration
blunted this increase (Figure 5g). It is possible that an attenuation
of the MR-mediated stress response accounts for some of the
beneﬁcial effect of ﬂuoxetine on behavior.
Chronic stress may affect expression of genes important for
serotonergic signaling. We therefore analyzed the level and
expression pattern of brain serta. Whole-brain quantitative
RT-PCR revealed a subtle increase in serta expression between
stressed and non-stressed states in WT, mutants and hetero-
zygotes (Figure 5h). This trend is detectable by 4 days of CMS and
is signiﬁcant by 2 weeks (Supplementary Figure S7). Fluoxetine
(4 days or 2 weeks) lowers serta levels to baseline levels in
CMS-exposed ﬁsh, whereas diazepam does not, even when
applied continuously for 4 days (Supplementary Figure S7). Thus,
regulation of serta transcription could be one mechanism by
which the therapeutic effects of ﬂuoxetine and diazepam differ.
Our measurements also suggested that serotonin regulation
during stress and the effect of SSRIs are not disrupted by the
grs357 mutation. In-situ hybridization, however, offered a more
complex picture. Here, serta mRNA appeared to be absent from
the superior raphe nucleus of the mutants (Figure 5i). Pretectal
nuclei expressed apparently normal levels of serta (Supplementary
Figure S8). Together, the observed ﬂuoxetine effects on behavior,
GR and MR expression, as well as apparent serta misregulation in
the grs357 mutant, are consistent with the notion that glucocorti-
coid signaling is cross-linked with the serotonergic transmitter
system, and that a serotonin imbalance predisposes depression-
like behavior in zebraﬁsh.
DISCUSSION
We have presented evidence that disruption of GR causes a
syndrome in adult zebraﬁsh that resembles an affective disorder.
The syndrome carries the molecular signature of chronic stress
and the behavioral proﬁle of depression, including decreased
exploratory behavior and impaired habituation to repeated
exposure to an anxiogenic environment. Molecularly, the mutation
results in substitution of a highly conserved arginine (R) to
cysteine (C) in the second zinc ﬁnger motif of the GR protein,
which is essential for DNA binding. This change abolishes both
transcriptional repression and activation of target genes in a broad
range of in vitro assays, including those requiring binding of GR
homodimers to positive or negative GREs and heterodimerization
with NF-kB or AP-1. We conclude from these data that the
mutation has generated a null for most, if not all, genomic
functions of GR. In agreement with our ﬁndings on the molecular
consequences of this mutation in zebraﬁsh, a naturally occurring
mutation of the equivalent residue (R477) in human GR20,27,28 also
disrupted transcriptional regulation by GR. Moreover, mutation of
the corresponding amino acid residue in the androgen receptor
(R615) causes androgen insensitivity syndrome in humans,29
suggesting that this conserved arginine is essential for the
function of steroid hormone receptors in general.
We established that disruption of GR genomic activity results in
a hyperactivated HPA axis. In particular CRH, adrenocorticotropic
hormone and cortisol are chronically elevated. Consistent with an
exaggerated stress response, mutants overreact to an anxiogenic
environment, a novel tank in which they are isolated from
conspeciﬁcs. WT and heterozygous ﬁsh habituate both in the short
term (within the 10min of the individual trial) and long term
(between trials) to this stressful environment. Their behavior shifts
from freezing and location indifference to strong exploratory
swimming behavior near the walls. Homozygous mutants, on the
other hand, largely remain in a freezing posture and do not show
place preference between and during freezing bouts; they barely
habituate within a trial and even become sensitized between
trials. Treatments with diazepam and ﬂuoxetine reduce freezing
duration and wall-avoidance behavior in the mutants and also
augment and accelerate habituation in WT and heterozygotes.
In zebraﬁsh, wall-hugging behavior, or thigmotaxis, in the novel
tank appears to be an indicator of motivated, exploratory
behavior. In agreement with previous studies,30--32 we observed
that habituation to the novel tank results in a reduction of wall
avoidance. It has been reported that intermediate doses of
ethanol increased several indicators of anxiety, whereas thigmo-
taxis was decreased.33 On the other hand, d-lysergic acid
diethylamide reduced freezing and other anxiety-related beha-
viors, and simultaneously increased thigmotaxis.34 We show
here that anxiolytic and antidepressant treatments similarly result
in pronounced swimming near the walls. So, a consensus is
emerging that, at least in the small, well-lit containers, used by us
and others, ‘thigmotaxis’ increases as stress levels drop, and vice
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Figure 5. Effect of diazepam and fluoxetine on zebrafish behavior and gene expression. (a) Freezing indices of experienced fish before
(‘pretreatment’) and after diazepam (5mM, 30min) or vehicle (‘no drug’, 30min) treatments (n¼ 5, significant difference between mutant and
wild-type (WT) pre-treatment, *P¼ 0.019, analysis of variance (ANOVA) F ratio¼ 6.17; no significant difference between treated mutants and
WT, P¼ 0.066, ANOVA F ratio¼ 2.97; no significant combined effect genotype treatment, P¼ 0.3464, F ratio¼ 1.09; pooled data ANOVA:
degrees of freedom¼ 5, F ratio¼ 2.87, Po0.03). (b) Freezing indices of experienced fish after fluoxetine treatment (0.8 mM, 4 days). Same
controls as in the diazepam experiment (n¼ 10--36; significant difference between mutant and WT pre-treatment genotype difference,
**Po0.0012, ANOVA F ratio¼ 11.0; no significant difference between treated mutants and WT, P¼ 0.097, ANOVA F ratio¼ 2.38; no significant
combined effect genotype treatment, P¼ 0.62, F ratio¼ 0.62; pooled data ANOVA: degrees of freedom¼ 5, F ratio¼ 6.91, P¼ 104). (c) Heat
maps of location preferences. The heterozygous fish shows a mild preference for the corners and walls, which is greatly increased following
fluoxetine and diazepam treatments. Diazepam-treated fish (upper right panel) spent most of the time in the corners of the tank. The mutant
is similarly affected, although its wall avoidance does not reach the levels of the diazepam-treated heterozygote (lower right panel). (d) Plasma
cortisol levels of experienced mutants and heterozygotes, determined by enzyme immunoassay (EIA) before (‘non-stressed’) and after
behavioral testing (‘stressed’), following 4 days of fluoxetine (0.8 mM) or vehicle (‘no drug’) treatments (n¼ 2--8). Insert shows heterozygote
levels on a different y axis scale. Fluoxetine normalizes behavior without correcting cortisol levels (P40.05). (e) Plasma cortisol levels of naive
WT, mutants and heterozygotes, determined by radioimmunoassay following 2 weeks of fluoxetine (0.8 mM) or vehicle (‘untreated 2 weeks’)
treatments (n¼ 3--7). Cortisol is partially corrected after 2 weeks of fluoxetine administration (**Po0.001). (f-h) Reverse-transcriptase (RT)-PCR
expression data of gr, mr and serotonin transporter (serta) mRNA in total RNA extracted from whole brain of non-stressed fish (‘Untreated’);
following 2 weeks of chronic mild stress (‘2 weeks CMS’); 50--90min of 5 mM diazepam treatment (‘Diazepam 5 mM’); or 2 weeks of CMS with
0.8mM fluoxetine treatment (‘2 weeks CMSþ Fluoxetine 0.8 mM’; n¼ 3--9 fish per group; *Po0.01, **Po0.0001). gr mRNA is largely unaltered by
stress and drug treatments (f ). mr mRNA is similar between genotypes, but upregulated in stressed fish of all genotypes and normalized by
fluoxetine (g). At the whole-brain transcript level, there is no significant difference in serta expression between experimental groups (h), but
see (i). (i) In-situ hybridizations on hindbrain sagittal sections reveal the absence or strong reduction of serta-expressing cells in the superior
raphe nucleus (SR) of the grs357 mutant.
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versa. This may appear counterintuitive, as it is opposite to what
has been reported in rat and mouse, but could be owed to
ecological differences between diurnal telosts and nocturnal
rodents. Zebraﬁsh are visual specialists. For them, moving to
the open ﬁeld when threatened, where they cannot be ambushed
by a hidden predator and can seek conspeciﬁcs to shoal with,
may be an adaptive strategy. Further work is needed to resolve this
important issue.
Is the freezing behavior observed here more closely related to
anxiety or to depression? The pharmacology leaves this question
unanswered, as freezing is reversed by both anxiolytic (diazepam)
and antidepressant drugs (ﬂuoxetine). So, we have to consider
behavioral parameters. Anxiety in zebraﬁsh is characterized
by darting across the tank and active exploration of escape
routes.23,24,30 We did not observe this behavior in our mutants.
Also, behavioral differences between mutants and WTs became
only detectable after repeated exposures, suggesting long-lasting,
experience-dependent effects akin to learned helplessness.
Although we cannot know the emotions of a ﬁsh, we therefore
interpret the freezing behavior and immobility of grs357 mutants as
manifestation of a syndrome more similar to depression than
to anxiety. It cannot be excluded, however, that the mutant’s
behavior may reﬂect an extreme form of anxiety or that the
boundaries of anxiety, panic, catatonia, despair and depression
may be ﬂuid for teleost ﬁsh.
Successful treatment with ﬂuoxetine, as well as social interac-
tions with other zebraﬁsh leave the high cortisol levels of the
mutant initially unchanged, apparently bypassing the HPA axis.
Only after 2 weeks of ﬂuoxetine treatment did we observe a
reduction of cortisol. Thus, although disruption of GR-mediated
transcriptional control is sufﬁcient to cause an affective disorder
in this zebraﬁsh model, subsequent correction of cortisol levels is
not necessary for normalization of the behavior. Instead, other
stress-associated mechanisms, presumably in the emotional centers
of the brain, are independently targeted by SSRIs and other
successful treatments. Cortisol reduction occurs with a delay
and appears to be a consequence, rather than a cause, of the
successful therapy.
The neural mechanism by which HPA dysregulation conditions
behavioral responses in zebraﬁsh is currently unknown. There is
circumstantial evidence that interactions between CRH and the
serotonergic systems may be involved. A subsensitivity of the
serotonin system is strongly associated with depression in
mammals.35,36 In teleosts and amphibians, intracerebral injection
of CRH modulates locomotor activity and place preference in a
context-dependent manner. These CRH-induced behaviors are
strongly potentiated or inhibited by co-administration of ﬂuox-
etine or a 5-HT1A receptor antagonist, respectively.
37,38 In our
zebraﬁsh grs357 mutant, brain Serta expression appears to be
decreased in the superior raphe nucleus. Serotonergic neurons
from the raphe nucleus project broadly to many areas of the CNS
and are important modulators of brain plasticity and neurogenesis,
as well as locomotion and affective behaviors.39 The therapeutic
potency of SSRIs observed above could be related to restoration
of normal serotonin function in the superior raphe nucleus with
distributed effects on forebrain or brainstem motor circuits.
In addition, as suggested by their slow time course of action,
SSRIs might affect gene transcription, for example, dampen the
stress-induced expression of MR, as shown here in zebraﬁsh.
Several mouse lines with conditionally altered GR expression or
function have been generated40,41 (constitutive knockout of GR
is embryonic lethal in the mouse). Depressive behaviors were
observed in mice with heterozygotic GR knockout42 or forebrain-
restricted GR knockout.43 However, total neuronal or glial GR
knockouts44 or antisense GR knockdown,45 either resulted in reduced
anxiety or had no measurable effect on behavior. Paradoxically, a
transgenic mouse with overexpression of GR in the forebrain
showed increased anxiety and/or depression-like behavior after
exposure to CMS.46 Thus, behavioral results in the mouse cannot
be easily reconciled with data in human patients, maybe because
tissue-restricted manipulations have incomplete or complex effects
on the HPA axis and/or the limbic system.
Transcriptional regulation by GR is not the only mediator of
cortisol signaling in the brain. Transgenic overexpression of MR in
the forebrain was recently shown to dampen anxiety-related
behavior in mouse.47 In addition to the classical genomic activity
of GR and MR, an alternative rapid, non-genomic signaling route
for cortisol was shown, which may or may not involve GR or MR.48
Apparently, this signaling is crucial for mediating glucocorticoid
effects on neuronal activity and plasticity, facilitating or inhibiting
signaling of ion channels and neurotransmitter receptors.49--51
Both non-genomic effects and MR-dependent signaling by cortisol
are expected to be intact in the grs357 mutant, or may even be
exaggerated because of increased cortisol levels. As grs357 mutants
lack all GR genomic activity, it may be a useful tool for
disentangling the contributions of these other signaling pathways
in the stress response.
Together, our ﬁndings demonstrate the striking degree of
evolutionary conservation in the neuroendocrine circuits regulat-
ing emotion in vertebrates. Our data strongly support the
hypothesis4 that excessive activation of the HPA axis, by acquired
or (in the case of this novel ﬁsh mutant) inherited glucocorticoid
resistance, is an important contributor to the development of
depression. As a diurnal species with cortisol rhythms similar
to humans,1 zebraﬁsh may provide a useful model system for
neuropsychiatric research, complementary to the widely used
rodent models. In a future application, our zebraﬁsh gr mutant
could potentially be used as a small-molecule screening tool52 for
the discovery of novel antidepressant pharmacologies.
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